Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Maria V Vedunova"'
Autor:
Iuliia Efimova, Elena Catanzaro, Louis Van der Meeren, Victoria D Turubanova, Hamida Hammad, Tatiana A Mishchenko, Maria V Vedunova, Carmela Fimognari, Claus Bachert, Frauke Coppieters, Steve Lefever, Andre G Skirtach, Olga Krysko, Dmitri V Krysko
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Immunotherapy represents the future of clinical cancer treatment. The type of cancer cell death determines the antitumor immune response and thereby contributes to the efficacy of anticancer therapy and long-term survival of patients. Indu
Externí odkaz:
https://doaj.org/article/2a503d3f5540469a8ba20ba437a6ab07
Autor:
Tatiana A. Mishchenko, Maria O. Klimenko, Evgenii L. Guryev, Alexander G. Savelyev, Dmitri V. Krysko, Sergey V. Gudkov, Evgeny V. Khaydukov, Andrei V. Zvyagin, Maria V. Vedunova
Publikováno v:
Frontiers in Chemistry, Vol 12 (2024)
Targeted drug delivery for primary brain tumors, particularly gliomas, is currently a promising approach to reduce patient relapse rates. The use of substitutable scaffolds, which enable the sustained release of clinically relevant doses of anticance
Externí odkaz:
https://doaj.org/article/8bcba51acd8b4706a260f582b35579a7
Autor:
Faye Naessens, Robin Demuynck, Olga Vershinina, Iuliia Efimova, Mariia Saviuk, Greet De Smet, Tatiana A. Mishchenko, Maria V. Vedunova, Olga Krysko, Elena Catanzaro, Dmitri V. Krysko
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionImmunogenic cell death (ICD) has emerged as a novel option for cancer immunotherapy. The key determinants of ICD encompass antigenicity (the presence of antigens) and adjuvanticity, which involves the release of damage-associated molecula
Externí odkaz:
https://doaj.org/article/897c16da81f44a31844f4d82d76e5dbb
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 13, p 7122 (2024)
The notion of notable anatomical, biochemical, and behavioral distinctions within male and female brains has been a contentious topic of interest within the scientific community over several decades. Advancements in neuroimaging and molecular biologi
Externí odkaz:
https://doaj.org/article/02c0bcf2f1e0440abbec38ff099117ea
Autor:
Tatiana A. Mishchenko, Victoria D. Turubanova, Ekaterina N. Gorshkova, Olga Krysko, Maria V. Vedunova, Dmitri V. Krysko
Publikováno v:
Frontiers in Immunology, Vol 14 (2024)
Glioma is the most common primary brain tumor, characterized by a consistently high patient mortality rate and a dismal prognosis affecting both survival and quality of life. Substantial evidence underscores the vital role of the immune system in era
Externí odkaz:
https://doaj.org/article/671e1b3822144468a9b6f04b69832d42
Autor:
Elena V. Mitroshina, Maria V. Vedunova
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 9, p 4581 (2024)
Understanding the molecular underpinnings of neurodegeneration processes is a pressing challenge for medicine and neurobiology. Alzheimer’s disease (AD) and Parkinson’s disease (PD) represent the most prevalent forms of neurodegeneration. To date
Externí odkaz:
https://doaj.org/article/65aea92b600143eba41be5facd266e70
Autor:
Tatiana A. Mishchenko, Maria O. Klimenko, Alisa I. Kuznetsova, Roman S. Yarkov, Alexander G. Savelyev, Anastasia V. Sochilina, Alexandra O. Mariyanats, Vladimir K. Popov, Evgeny V. Khaydukov, Andrei V. Zvyagin, Maria V. Vedunova
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 10 (2022)
Brain tissue reconstruction posttraumatic injury remains a long-standing challenge in neurotransplantology, where a tissue-engineering construct (scaffold, SC) with specific biochemical properties is deemed the most essential building block. Such thr
Externí odkaz:
https://doaj.org/article/6a6d24f87e354a179fad9c84502dd6eb
Autor:
Victoria D. Turubanova, Tatiana A. Mishchenko, Irina V. Balalaeva, Iuliia Efimova, Nina N. Peskova, Larisa G. Klapshina, Svetlana A. Lermontova, Claus Bachert, Olga Krysko, Maria V. Vedunova, Dmitri V. Krysko
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Abstract The immunogenicity of dying cancer cells determines the efficacy of anti-cancer therapy. Photodynamic therapy (PDT) can induce immunogenic cell death (ICD), which is characterized by the emission of damage-associated molecular patterns (DAMP
Externí odkaz:
https://doaj.org/article/41e549963f9b4302b7339409a3df2132
Autor:
Victoria D. Turubanova, Irina V. Balalaeva, Tatiana A. Mishchenko, Elena Catanzaro, Razan Alzeibak, Nina N. Peskova, Iuliia Efimova, Claus Bachert, Elena V. Mitroshina, Olga Krysko, Maria V. Vedunova, Dmitri V. Krysko
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-13 (2019)
Abstract Background Anti-cancer therapy is more successful when it can also induce an immunogenic form of cancer cell death (ICD). Therefore, when developing new treatment strategies, it is extremely important to choose methods that induce ICD and th
Externí odkaz:
https://doaj.org/article/74d9f8330b3f4837b030647ecc6865c1
Autor:
Angelina O. Kustova, Maria S. Gavrish, Marina A. Sergeeva, Daria A. Avlasenko, Anna O. Kiseleva, Ekaterina A. Epifanova, Alexey A. Babaev, Tatiana A. Mishchenko, Maria V. Vedunova
Publikováno v:
Brain Sciences, Vol 12, Iss 8, p 1039 (2022)
The high prevalence of diagnosed cases of severe neurological disorders, a significant proportion of which are epilepsy, contributes to a high level of mortality and disability in the population. Neurotrophic factors BDNF and GNDF are considered prom
Externí odkaz:
https://doaj.org/article/86057363dd3f4d1690f26d22b1a67287